<?xml version="1.0" encoding="UTF-8"?><!-- Normalized for easier text mining. --><xocs:doc xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.elsevier.com/xml/ja/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://schema.elsevier.com/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta><xocs:content-family>serial</xocs:content-family><xocs:content-type>JL</xocs:content-type><xocs:cid>286331</xocs:cid><xocs:srctitle>Stem Cell Reports</xocs:srctitle><xocs:normalized-srctitle>STEMCELLREPORTS</xocs:normalized-srctitle><xocs:orig-load-date>2013-09-26</xocs:orig-load-date><xocs:ew-transaction-id>2013-10-12T20:44:18</xocs:ew-transaction-id><xocs:eid>1-s2.0-S2213671113000738</xocs:eid><xocs:pii-formatted>S2213-6711(13)00073-8</xocs:pii-formatted><xocs:pii-unformatted>S2213671113000738</xocs:pii-unformatted><xocs:doi>10.1016/j.stemcr.2013.08.007</xocs:doi><xocs:item-stage>S300</xocs:item-stage><xocs:item-version-number>S300.1</xocs:item-version-number><xocs:item-weight>FULL-TEXT</xocs:item-weight><xocs:hub-eid>1-s2.0-S2213671113X00050</xocs:hub-eid><xocs:timestamp>2014-02-03T15:49:17.288084-05:00</xocs:timestamp><xocs:issns><xocs:issn-primary-formatted>2213-6711</xocs:issn-primary-formatted><xocs:issn-primary-unformatted>22136711</xocs:issn-primary-unformatted></xocs:issns><xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type><xocs:funding-body-id>NONE</xocs:funding-body-id><xocs:crossmark>true</xocs:crossmark><xocs:vol-first>1</xocs:vol-first><xocs:iss-first>4</xocs:iss-first><xocs:vol-iss-suppl-text>Volume 1, Issue 4</xocs:vol-iss-suppl-text><xocs:sort-order>2</xocs:sort-order><xocs:first-fp>283</xocs:first-fp><xocs:last-lp>292</xocs:last-lp><xocs:pages><xocs:first-page>283</xocs:first-page><xocs:last-page>292</xocs:last-page></xocs:pages><xocs:cover-date-orig><xocs:start-date>20131015</xocs:start-date></xocs:cover-date-orig><xocs:cover-date-text>15 October 2013</xocs:cover-date-text><xocs:cover-date-start>2013-10-15</xocs:cover-date-start><xocs:cover-date-year>2013</xocs:cover-date-year><xocs:hub-sec><xocs:hub-sec-title>Report</xocs:hub-sec-title></xocs:hub-sec><xocs:document-type>article</xocs:document-type><xocs:document-subtype>sco</xocs:document-subtype><xocs:copyright-line>Copyright Â© 2013 The Authors. Published by Elsevier Inc. All rights reserved.</xocs:copyright-line><xocs:normalized-article-title>DIRECTCOMPARISONAUTOLOGOUSALLOGENEICTRANSPLANTATIONIPSCDERIVEDNEURALCELLSINBRAINANONHUMANPRIMATE</xocs:normalized-article-title><xocs:normalized-first-auth-surname>MORIZANE</xocs:normalized-first-auth-surname><xocs:normalized-first-auth-initial>A</xocs:normalized-first-auth-initial><xocs:item-toc><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Results</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>iPSCs Derived from Nonhuman Primates Differentiate into DA Neurons</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Expression of Major Histocompatibility Complex by Monkey iPSCs In Vitro</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Autografts Elicit Only a Minimal Immune Response in the Primate Brain</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>DA Neurons Survive in Both Types of Grafts, but a Higher Number Are Observed in Autografts</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Experimental Procedures</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Nonhuman Primates</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Generation and Neural Differentiation of iPSCs</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Genotyping of MHC</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Immunostaining and Histological Analyses</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>MRI and PET Studies</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Transplantation</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Statistics</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:acknowledgment"><xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:appendices"><xocs:item-toc-section-title>Supplemental Information</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:bibliography"><xocs:item-toc-section-title>References</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc><xocs:references><xocs:ref-info refid="sref1"><xocs:ref-normalized-surname>AKESSON</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>56</xocs:ref-first-fp><xocs:ref-last-lp>67</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref2"><xocs:ref-normalized-surname>ARAKI</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>100</xocs:ref-first-fp><xocs:ref-last-lp>104</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref3"><xocs:ref-normalized-surname>CHAMBERS</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>715</xocs:ref-first-fp><xocs:ref-last-lp>720</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref4"><xocs:ref-normalized-surname>CHASTAIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>265</xocs:ref-first-fp><xocs:ref-last-lp>274</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref5"><xocs:ref-normalized-surname>DEBRUYNE</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>257</xocs:ref-first-fp><xocs:ref-last-lp>264</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref6"><xocs:ref-normalized-surname>DELEIDI</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>1052</xocs:ref-first-fp><xocs:ref-last-lp>1063</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref7"><xocs:ref-normalized-surname>EIRAKU</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>519</xocs:ref-first-fp><xocs:ref-last-lp>532</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref8"><xocs:ref-normalized-surname>EMBORG</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>646</xocs:ref-first-fp><xocs:ref-last-lp>650</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref9"><xocs:ref-normalized-surname>FREED</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>710</xocs:ref-first-fp><xocs:ref-last-lp>719</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref10"><xocs:ref-normalized-surname>GUHA</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>407</xocs:ref-first-fp><xocs:ref-last-lp>412</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref11"><xocs:ref-normalized-surname>HUDSON</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>32</xocs:ref-first-fp><xocs:ref-last-lp>36</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref12"><xocs:ref-normalized-surname>KORDOWER</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>213</xocs:ref-first-fp><xocs:ref-last-lp>219</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref13"><xocs:ref-normalized-surname>LINDVALL</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>539</xocs:ref-first-fp><xocs:ref-last-lp>548</xocs:ref-last-lp><xocs:ref-normalized-initial>O</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref14"><xocs:ref-normalized-surname>MARIA</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>1548</xocs:ref-first-fp><xocs:ref-last-lp>1562</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref15"><xocs:ref-normalized-surname>MORIZANE</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>117</xocs:ref-first-fp><xocs:ref-last-lp>126</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref16"><xocs:ref-normalized-surname>NAKATSUJI</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>739</xocs:ref-first-fp><xocs:ref-last-lp>740</xocs:ref-last-lp><xocs:ref-normalized-initial>N</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref17"><xocs:ref-normalized-surname>OKITA</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>409</xocs:ref-first-fp><xocs:ref-last-lp>412</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref18"><xocs:ref-normalized-surname>OKITA</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>458</xocs:ref-first-fp><xocs:ref-last-lp>466</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref19"><xocs:ref-normalized-surname>OLANOW</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>403</xocs:ref-first-fp><xocs:ref-last-lp>414</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref20"><xocs:ref-normalized-surname>REDMOND</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>103</xocs:ref-first-fp><xocs:ref-last-lp>116</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref21"><xocs:ref-normalized-surname>SHAH</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>573</xocs:ref-first-fp><xocs:ref-last-lp>581</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref22"><xocs:ref-normalized-surname>SHINODA</xocs:ref-normalized-surname><xocs:ref-pub-year>1995</xocs:ref-pub-year><xocs:ref-first-fp>180</xocs:ref-first-fp><xocs:ref-last-lp>195</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref23"><xocs:ref-normalized-surname>VOWINCKEL</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>345</xocs:ref-first-fp><xocs:ref-last-lp>353</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref24"><xocs:ref-normalized-surname>ZHAO</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>212</xocs:ref-first-fp><xocs:ref-last-lp>215</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info></xocs:references><xocs:attachment-metadata-doc><xocs:attachment-set-type>item</xocs:attachment-set-type><xocs:pii-formatted>S2213-6711(13)00073-8</xocs:pii-formatted><xocs:pii-unformatted>S2213671113000738</xocs:pii-unformatted><xocs:eid>1-s2.0-S2213671113000738</xocs:eid><xocs:doi>10.1016/j.stemcr.2013.08.007</xocs:doi><xocs:cid>286331</xocs:cid><xocs:timestamp>2013-10-15T11:46:36.378743-04:00</xocs:timestamp><xocs:path>/286331/1-s2.0-S2213671113X00050/1-s2.0-S2213671113000738/</xocs:path><xocs:cover-date-start>2013-10-15</xocs:cover-date-start><xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type><xocs:funding-body-id>NONE</xocs:funding-body-id><xocs:attachments><xocs:web-pdf><xocs:attachment-eid>1-s2.0-S2213671113000738-main.pdf</xocs:attachment-eid><xocs:filename>main.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:pdf-optimized>true</xocs:pdf-optimized><xocs:filesize>4033684</xocs:filesize><xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose><xocs:web-pdf-page-count>10</xocs:web-pdf-page-count><xocs:web-pdf-images><xocs:web-pdf-image><xocs:attachment-eid>1-s2.0-S2213671113000738-main_1.png</xocs:attachment-eid><xocs:filename>main_1.png</xocs:filename><xocs:extension>png</xocs:extension><xocs:filesize>124968</xocs:filesize><xocs:pixel-height>849</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type><xocs:pdf-page-num>1</xocs:pdf-page-num></xocs:web-pdf-image></xocs:web-pdf-images></xocs:web-pdf><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000738-gr3.jpg</xocs:attachment-eid><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>180138</xocs:filesize><xocs:pixel-height>975</xocs:pixel-height><xocs:pixel-width>716</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000738-gr4.jpg</xocs:attachment-eid><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>186633</xocs:filesize><xocs:pixel-height>862</xocs:pixel-height><xocs:pixel-width>694</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000738-fx1.jpg</xocs:attachment-eid><xocs:file-basename>fx1</xocs:file-basename><xocs:abstract-attachment>true</xocs:abstract-attachment><xocs:filename>fx1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>46183</xocs:filesize><xocs:pixel-height>359</xocs:pixel-height><xocs:pixel-width>375</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000738-gr2.jpg</xocs:attachment-eid><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>150544</xocs:filesize><xocs:pixel-height>912</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000738-gr1.jpg</xocs:attachment-eid><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>173184</xocs:filesize><xocs:pixel-height>663</xocs:pixel-height><xocs:pixel-width>769</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000738-gr3.sml</xocs:attachment-eid><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>7580</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>120</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000738-gr4.sml</xocs:attachment-eid><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>10399</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>132</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000738-fx1.sml</xocs:attachment-eid><xocs:file-basename>fx1</xocs:file-basename><xocs:abstract-attachment>true</xocs:abstract-attachment><xocs:filename>fx1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>7645</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>171</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000738-gr2.sml</xocs:attachment-eid><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>5137</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>118</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000738-gr1.sml</xocs:attachment-eid><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>12128</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>190</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2213671113000738-mmc1.pdf</xocs:attachment-eid><xocs:file-basename>mmc1</xocs:file-basename><xocs:filename>mmc1.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:filesize>967787</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment></xocs:attachments></xocs:attachment-metadata-doc><xocs:refkeys><xocs:refkey3>MORIZANEX2013X283</xocs:refkey3><xocs:refkey4lp>MORIZANEX2013X283X292</xocs:refkey4lp><xocs:refkey4ai>MORIZANEX2013X283XA</xocs:refkey4ai><xocs:refkey5>MORIZANEX2013X283X292XA</xocs:refkey5></xocs:refkeys><xocs:open-access><xocs:oa-article-status is-open-access="1" is-open-archive="0">Full</xocs:oa-article-status><xocs:oa-access-effective-date>2013-08-30T15:50:17Z</xocs:oa-access-effective-date><xocs:oa-sponsor><xocs:oa-sponsor-type>ElsevierWaived</xocs:oa-sponsor-type></xocs:oa-sponsor><xocs:oa-user-license>http://creativecommons.org/licenses/by/3.0/</xocs:oa-user-license></xocs:open-access></xocs:meta><xocs:serial-item><article xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" docsubtype="sco" version="5.2" xml:lang="en"><item-info><jid>STEMCR</jid><aid>32</aid><ce:pii>S2213-6711(13)00073-8</ce:pii><ce:doi>10.1016/j.stemcr.2013.08.007</ce:doi><ce:copyright type="other" year="2013">The Authors</ce:copyright></item-info><ce:floats><ce:figure id="fig1"><ce:label>Figure 1</ce:label><ce:caption id="cap0010"><ce:simple-para id="fspara0010" view="all">Characterization of Primate iPSCs and iPSC-Derived Neurons</ce:simple-para><ce:simple-para id="fspara0015" view="all">(A-H) Phase-contrast images (A, B, and G) and immunostaining for pluripotent markers (C-F) of iPSCs (T7). GFP was detected during live imaging (G and H) in the same field.</ce:simple-para><ce:simple-para id="fspara0020" view="all">(I-M) Teratoma formation at 3 months after transplantation in the testes of SCID mice. H&amp;E staining of the sections showed histological features of the neuroepithelium (J), cartilage (K), muscle (L) and gut-like epithelium (M).</ce:simple-para><ce:simple-para id="fspara0025" view="all">(N) The protocol used for neural differentiation.</ce:simple-para><ce:simple-para id="fspara0030" view="all">(O) Expression analyses of neural markers and Oct4 by flow cytometry. The negative control was a cell sample stained only by secondary antibody (PSA-NCAM) or the isotype control (TUBÎ²III and OCT4). The positive control for OCT4 was undifferentiated (day 0) iPSCs.</ce:simple-para><ce:simple-para id="fspara0035" view="all">(P) qPCR for the differentiation of donor cells. The data are shown as the means Â± SD (n = 4 independent experiments).</ce:simple-para><ce:simple-para id="fspara0040" view="all">(Q) Immunostaining of primate iPSC-derived neurons on day 39.</ce:simple-para><ce:simple-para id="fspara0045" view="all">(R) Quantification of immunocytochemical analyses for each iPSC line. Data are shown as the means Â± SD (n = 3 independent experiments). SER, serotonin, TUBÎ²III, Î²-tubulin class III. Scale bars: 200 Î¼m in (A)-(H), 50 Î¼m in insets of (C)-(F), 100 Î¼m in (J)-(M) and (Q).</ce:simple-para><ce:simple-para id="fspara0050" view="all">See also <ce:cross-ref refid="app2" id="crosref0405">Figure S1</ce:cross-ref> and <ce:cross-ref refid="app2" id="crosref0410">Tables S2</ce:cross-ref> and <ce:cross-ref refid="app2" id="crosref0415">S3</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr1"/></ce:figure><ce:figure id="fig2"><ce:label>Figure 2</ce:label><ce:caption id="cap0015"><ce:simple-para id="fspara0055" view="all">Identification of MHC Expression and Typing of Donor Cells</ce:simple-para><ce:simple-para id="fspara0060" view="all">(A) Flow-cytometric analyses for MHC-I (HLA-A, HLA-B, and HLA-C). Incubation of the cells with IFN-Î³ for 48 hr increased the MHC-I expression (green).</ce:simple-para><ce:simple-para id="fspara0065" view="all">(B) Temporal MHC-I expression analysis of monkey iPSCs by qPCR. The data were obtained from three (n = 3 for fibro iPSCs) or five (n = 5 for blood iPSCs) different experiments. Data are shown as the means Â± SD.</ce:simple-para><ce:simple-para id="fspara0070" view="all">(C and E) Monkey MHC-I (Mafa) allele sequences detected by next-generation sequencing (C) and cluster analysis of the monkey MHCs (E). The colored letters indicate a comparatively high expression level of the MHC-I allele, comprising &gt;10% of cDNA sequence reads. The gray background indicates the <ce:italic>MHC-A</ce:italic> allele, and the others indicate the <ce:italic>MHC-B</ce:italic> allele.</ce:simple-para><ce:simple-para id="fspara0075" view="all">(D) Combinations of donor cells and recipient animals. Episomal v., established with episomal vectors; P, passage number just before starting the differentiation of donor cells; Retro v., established with retrovirus vectors.</ce:simple-para><ce:simple-para id="fspara0080" view="all">See also <ce:cross-ref refid="app2" id="crosref0420">Figure S4</ce:cross-ref>D and <ce:cross-ref refid="app2" id="crosref0425">Tables S1-S3</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr2"/></ce:figure><ce:figure id="fig3"><ce:label>Figure 3</ce:label><ce:caption id="cap0020"><ce:simple-para id="fspara0085" view="all">Immune Responses following Autologous or Allogeneic Transplantation</ce:simple-para><ce:simple-para id="fspara0090" view="all">(A and B) [<ce:sup loc="pre">11</ce:sup>C]PK11195 PET study of the allografts in animal No. 10, in which the highest immune response was observed histologically. The illustration in (A) shows the method used for cell injection.</ce:simple-para><ce:simple-para id="fspara0095" view="all">(C) Temporal changes in the serum level of IFN-Î³. Bottom: a two-way ANOVA was performed with Bonferroni's multiple-comparisons test; n = 4 animals, <ce:sup loc="pre">â</ce:sup>p &lt; 0.05. Data are shown as the means Â± SEM.</ce:simple-para><ce:simple-para id="fspara0100" view="all">(D-H) Histological analyses of the host-resident microglia. The image of H&amp;E staining of animal No. 8 is shown as an anatomical reference for coronal sections (D). The arrowheads in (A) and (D) indicate the direction of the cell injections.</ce:simple-para><ce:simple-para id="fspara0105" view="all">(I-L) Histological analyses of infiltrating leukocytes.</ce:simple-para><ce:simple-para id="fspara0110" view="all">Scale bars: 1 cm (A), 2 mm (D), 100 Î¼m (E and I), and 20 Î¼m (F, G, K, and L). Quantitative data are presented as the means Â± SEM (n = 22 tracts). Ratio paired t tests were performed for the auto- and allo-tracts. <ce:sup loc="pre">âââ</ce:sup>p = 0.0003 (H, upper), <ce:sup loc="pre">ââ</ce:sup>p = 0.0015 (H, lower), <ce:sup loc="pre">ââ</ce:sup>p = 0.0035 (J, upper), <ce:sup loc="pre">â</ce:sup>p = 0.0122 (J, lower). All of the PET, MRI, and histological images show coronal sections.</ce:simple-para><ce:simple-para id="fspara0115" view="all">See also <ce:cross-ref refid="app2" id="crosref0430">Figures S2-S4</ce:cross-ref> and <ce:cross-ref refid="app2" id="crosref0435">Table S3</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr3"/></ce:figure><ce:figure id="fig4"><ce:label>Figure 4</ce:label><ce:caption id="cap0025"><ce:simple-para id="fspara0120" view="all">Graft Survival in a Primate Brain</ce:simple-para><ce:simple-para id="fspara0125" view="all">(A-P) Histological analyses of a brain section with H&amp;E staining, and the immunohistochemical findings.</ce:simple-para><ce:simple-para id="fspara0130" view="all">(K) Quantitative analyses of the graft volume.</ce:simple-para><ce:simple-para id="fspara0135" view="all">(L and M) Survival of TH<ce:sup loc="post">+</ce:sup> neurons in the grafts.</ce:simple-para><ce:simple-para id="fspara0140" view="all">(N and O) The TH<ce:sup loc="post">+</ce:sup> neurons expressed markers of the midbrain phenotype: Foxa2 (N) and Nurr1 (O).</ce:simple-para><ce:simple-para id="fspara0145" view="all">(P) The DAT was also positively stained.</ce:simple-para><ce:simple-para id="fspara0150" view="all">(Q-S) Magnetic resonance images of a representative animal (No. 6, autograft) at 3 months after the transplant. The arrowheads indicate the directions of the cell injections. (Q) coronal, (R) axial, and (S) sagittal. The letter L indicates the left side.</ce:simple-para><ce:simple-para id="fspara0155" view="all">Scale bars: 2 mm (A, B, D, F, H, and J), 50 Î¼m (C, E, G, I, N, O, and P), and 1 cm (Q-S). Quantitative data are presented as the mean Â± SEM (n = 22 tracts). Ratio paired t tests were performed for the auto- and allo-tracts: <ce:sup loc="pre">ââ</ce:sup>p = 0.0021 (L), <ce:sup loc="pre">ââ</ce:sup>p = 0.0088 (M).</ce:simple-para><ce:simple-para id="fspara0160" view="all">See also <ce:cross-ref refid="app2" id="crosref0440">Figure S4</ce:cross-ref> and <ce:cross-ref refid="app2" id="crosref0445">Table S3</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr4"/></ce:figure></ce:floats><head><ce:article-footnote><ce:note-para id="ntpara9010" view="all">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</ce:note-para></ce:article-footnote><ce:dochead id="dhead0010"><ce:textfn>Report</ce:textfn></ce:dochead><ce:title id="title0010">Direct Comparison of Autologous and Allogeneic Transplantation of iPSC-Derived Neural Cells in the Brain of a Nonhuman Primate</ce:title><ce:author-group id="augrp0010"><ce:author id="au1"><ce:given-name>Asuka</ce:given-name><ce:surname>Morizane</ce:surname><ce:cross-ref refid="aff1" id="crosref0010"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au2"><ce:given-name>Daisuke</ce:given-name><ce:surname>Doi</ce:surname><ce:cross-ref refid="aff1" id="crosref0015"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au3"><ce:given-name>Tetsuhiro</ce:given-name><ce:surname>Kikuchi</ce:surname><ce:cross-ref refid="aff1" id="crosref0020"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au4"><ce:given-name>Keisuke</ce:given-name><ce:surname>Okita</ce:surname><ce:cross-ref refid="aff1" id="crosref0025"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au5"><ce:given-name>Akitsu</ce:given-name><ce:surname>Hotta</ce:surname><ce:cross-ref refid="aff1" id="crosref0030"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2" id="crosref0035"><ce:sup loc="post">2</ce:sup></ce:cross-ref><ce:cross-ref refid="aff3" id="crosref0040"><ce:sup loc="post">3</ce:sup></ce:cross-ref></ce:author><ce:author id="au6"><ce:given-name>Toshiyuki</ce:given-name><ce:surname>Kawasaki</ce:surname><ce:cross-ref refid="aff4" id="crosref0045"><ce:sup loc="post">4</ce:sup></ce:cross-ref></ce:author><ce:author id="au7"><ce:given-name>Takuya</ce:given-name><ce:surname>Hayashi</ce:surname><ce:cross-ref refid="aff5" id="crosref0050"><ce:sup loc="post">5</ce:sup></ce:cross-ref></ce:author><ce:author id="au8"><ce:given-name>Hirotaka</ce:given-name><ce:surname>Onoe</ce:surname><ce:cross-ref refid="aff4" id="crosref0055"><ce:sup loc="post">4</ce:sup></ce:cross-ref></ce:author><ce:author id="au9"><ce:given-name>Takashi</ce:given-name><ce:surname>Shiina</ce:surname><ce:cross-ref refid="aff6" id="crosref0060"><ce:sup loc="post">6</ce:sup></ce:cross-ref></ce:author><ce:author id="au10"><ce:given-name>Shinya</ce:given-name><ce:surname>Yamanaka</ce:surname><ce:cross-ref refid="aff1" id="crosref0065"><ce:sup loc="post">1</ce:sup></ce:cross-ref></ce:author><ce:author id="au11"><ce:given-name>Jun</ce:given-name><ce:surname>Takahashi</ce:surname><ce:cross-ref refid="aff1" id="crosref0070"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff7" id="crosref0075"><ce:sup loc="post">7</ce:sup></ce:cross-ref><ce:cross-ref refid="aff8" id="crosref0080"><ce:sup loc="post">8</ce:sup></ce:cross-ref><ce:cross-ref refid="cor1" id="crosref0085"><ce:sup loc="post">â</ce:sup></ce:cross-ref><ce:e-address type="email" id="eadd0010">jbtaka@cira.kyoto-u.ac.jp</ce:e-address></ce:author><ce:affiliation id="aff1"><ce:label>1</ce:label><ce:textfn>Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan</ce:textfn></ce:affiliation><ce:affiliation id="aff2"><ce:label>2</ce:label><ce:textfn>PRESTO, Japan Science and Technology Agency, Kawaguchi 332-0012, Japan</ce:textfn></ce:affiliation><ce:affiliation id="aff3"><ce:label>3</ce:label><ce:textfn>Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University, Kyoto 606-8501, Japan</ce:textfn></ce:affiliation><ce:affiliation id="aff4"><ce:label>4</ce:label><ce:textfn>Bio-function Imaging Team, RIKEN Center for Life Science Technologies (RIKEN CLST), Kobe 650-0047, Japan</ce:textfn></ce:affiliation><ce:affiliation id="aff5"><ce:label>5</ce:label><ce:textfn>Functional Architecture Imaging Unit, RIKEN Center for Life Science Technologies (RIKEN CLST), Kobe 650-0047, Japan</ce:textfn></ce:affiliation><ce:affiliation id="aff6"><ce:label>6</ce:label><ce:textfn>Department of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara 259-1143, Japan</ce:textfn></ce:affiliation><ce:affiliation id="aff7"><ce:label>7</ce:label><ce:textfn>Department of Biological Repair, Institute for Frontier Medical Sciences, Kyoto University, Kyoto 606-8507, Japan</ce:textfn></ce:affiliation><ce:affiliation id="aff8"><ce:label>8</ce:label><ce:textfn>Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan</ce:textfn></ce:affiliation><ce:correspondence id="cor1"><ce:label>â</ce:label><ce:text>Corresponding author</ce:text></ce:correspondence></ce:author-group><ce:date-received day="23" month="6" year="2013"/><ce:date-revised day="29" month="8" year="2013"/><ce:date-accepted day="30" month="8" year="2013"/><ce:miscellaneous id="misc0010">Published: September 26, 2013</ce:miscellaneous><ce:abstract id="abs0010" view="all" class="author"><ce:section-title id="sectitle0010">Summary</ce:section-title><ce:abstract-sec id="abssec0010" view="all"><ce:simple-para id="abspara0010" view="all">Induced pluripotent stem cells (iPSCs) provide the potential for autologous transplantation using cells derived from a patient's own cells. However, the immunogenicity of iPSCs or their derivatives has been a matter of controversy, and up to now there has been no direct comparison of autologous and allogeneic transplantation in the brains of humans or nonhuman primates. Here, using nonhuman primates, we found that the autologous transplantation of iPSC-derived neurons elicited only a minimal immune response in the brain. In contrast, the allografts caused an acquired immune response with the activation of microglia (IBA-1<ce:sup loc="post">+</ce:sup>/MHC class II<ce:sup loc="post">+</ce:sup>) and the infiltration of leukocytes (CD45<ce:sup loc="post">+</ce:sup>/CD3<ce:sup loc="post">+</ce:sup>). Consequently, a higher number of dopaminergic neurons survived in the autografts. Our results suggest that the autologous transplantation of iPSC-derived neural cells is advantageous for minimizing the immune response in the brain compared with allogeneic grafts.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="graphical" id="abs0015" view="all"><ce:section-title id="sectitle0015">Graphical Abstract</ce:section-title><ce:abstract-sec id="abssec0015" view="all"><ce:simple-para id="abspara0015" view="all"><ce:display><ce:figure id="undfig1"><ce:link locator="fx1"/></ce:figure></ce:display></ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="author-highlights" id="abs0020" view="all"><ce:section-title id="sectitle0020">Highlights</ce:section-title><ce:abstract-sec id="abssec0020" view="all"><ce:simple-para id="abspara0020" view="all"><ce:list id="ulist0010"><ce:list-item id="u0010"><ce:label>â¢</ce:label><ce:para id="p0010" view="all">iPSC-derived autografts cause only a minimal immune response in the primate brain</ce:para></ce:list-item><ce:list-item id="u0015"><ce:label>â¢</ce:label><ce:para id="p0015" view="all">Autografts have advantages over allografts even at an immune-privileged site</ce:para></ce:list-item><ce:list-item id="u0020"><ce:label>â¢</ce:label><ce:para id="p0020" view="all">Dopamine neurons survive even in allografts without immunosuppression</ce:para></ce:list-item></ce:list></ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="teaser" id="abs0025" view="all"><ce:abstract-sec id="abssec0025" view="all"><ce:simple-para id="abspara0025" view="all">The autologous transplantation of iPSC-derived neurons elicited only a minimal immune response in the brain. In contrast, the allografts caused an acquired immune response with the activation of microglia (IBA-1<ce:sup loc="post">+</ce:sup>/MHC class II<ce:sup loc="post">+</ce:sup>) and the infiltration of leukocytes (CD45<ce:sup loc="post">+</ce:sup>/CD3<ce:sup loc="post">+</ce:sup>). Autologous transplantation is advantageous for minimizing the immune response compared with allogeneic grafts.</ce:simple-para></ce:abstract-sec></ce:abstract></head><body view="all"><ce:sections><ce:section id="sec1" view="all"><ce:section-title id="sectitle0025">Introduction</ce:section-title><ce:para id="p0025" view="all">In recent studies, murine induced pluripotent stem cell (iPSC)-derived teratomas in the subcutaneous space induced an immune response in syngeneic mice (<ce:cross-ref refid="bib24" id="crosref0090">Zhao et al., 2011</ce:cross-ref>). In contrast, syngeneic transplantation of skin and bone marrow tissues (<ce:cross-ref refid="bib2" id="crosref0095">Araki et al., 2013</ce:cross-ref>) or endothelial, hepatic, and neuronal cells (<ce:cross-ref refid="bib10" id="crosref0100">Guha et al., 2013</ce:cross-ref>) derived from iPSCs showed a limited or no immune response, respectively. These rodent studies investigated the immunogenicity of teratomas, chimeric mouse-derived tissues, or ectopic grafts, but did not convincingly simulate the clinical situation.</ce:para><ce:para id="p0030" view="all">Parkinson's disease is one of the most promising targets for cell therapy with pluripotent stem cells, in which differentiated dopaminergic (DA) neurons are transplanted into the putamen of a patient's brain (<ce:cross-ref refid="bib13" id="crosref0105">Lindvall and BjÃ¶rklund, 2011</ce:cross-ref>). In order to assess the immunogenicity of iPSC-derived neural cells in a primate brain, we generated iPSCs from four cynomolgus monkeys and directly compared the autologous and allogeneic transplantation of iPSC-derived neural cells.</ce:para></ce:section><ce:section id="sec2" view="all"><ce:section-title id="sectitle0030">Results</ce:section-title><ce:section id="sec2.1" view="all"><ce:section-title id="sectitle0035">iPSCs Derived from Nonhuman Primates Differentiate into DA Neurons</ce:section-title><ce:para id="p0035" view="all">For the first two animals (Nos. 1 and 4), we established iPSCs from fibroblasts derived from the oral mucosa using retroviral vectors (<ce:cross-ref refid="bib17" id="crosref0110">Okita et al., 2011</ce:cross-ref>). For the other two animals (Nos. 6 and 8), we used peripheral blood mononuclear cells (PBMCs) with nonintegrating episomal vectors (<ce:cross-ref refid="bib18" id="crosref0115">Okita et al., 2013</ce:cross-ref>). We selected the best clone from each animal according to the following criteria: a stable embryonic stem cell (ESC)-like morphology of the colonies after passaging, expression of pluripotent markers, few or no integrated transgenes (<ce:cross-ref refid="fig1" id="crosref0120">Figures 1</ce:cross-ref><ce:float-anchor refid="fig1"/>A-1F; <ce:cross-ref refid="app2" id="crosref0125">Figure S1</ce:cross-ref> available online), and the potential for stable neural differentiation. A PCR analysis revealed that all of the clones with retroviral vectors showed apparent expression of remaining transgenes (<ce:cross-ref refid="app2" id="crosref0130">Figures S1</ce:cross-ref>C and S1D), whereas the clones with episomal vectors never did (<ce:cross-ref refid="app2" id="crosref0135">Figure S1</ce:cross-ref>F). To detect the iPSC-derived cells in a brain, we introduced GFP (<ce:cross-ref refid="fig1" id="crosref0140">Figures 1</ce:cross-ref>G and 1H). The selected clones of iPSCs had the potential to generate teratomas in the testes of a severe combined immunodeficiency (SCID) mouse within 12 weeks (<ce:cross-ref refid="fig1" id="crosref0145">Figures 1</ce:cross-ref>I-1M).</ce:para><ce:para id="p0040" view="all">To efficiently generate DA neurons from monkey iPSCs, we modified previously described protocols (<ce:cross-refs refid="bib7 bib3 bib15" id="crosrefs0010">Eiraku et al., 2008; Chambers et al., 2012; Morizane et al., 2011</ce:cross-refs>). Briefly, dissociated iPSCs were incubated in ultralow-attachment 96-well plates in medium containing inhibitors of bone morphogenetic protein (BMP) and Activin/NODAL signaling to initiate neural induction. To induce differentiation of the cells toward midbrain DA neurons, purmorphamine/FGF8 and FGF2/FGF20 were added sequentially (<ce:cross-ref refid="fig1" id="crosref0150">Figure 1</ce:cross-ref>N). During differentiation, the expression of a pluripotent marker (<ce:italic>OCT4</ce:italic>) gradually decreased, whereas the levels of neural and DA markers increased (<ce:cross-ref refid="fig1" id="crosref0155">Figures 1</ce:cross-ref>O and 1P). The differentiated neurons expressed markers characteristic of midbrain DA neurons (LMX1A, FOXA2, TH, and PITX3; <ce:cross-ref refid="fig1" id="crosref0160">Figures 1</ce:cross-ref>Q and 1R). Besides DA neurons, other types of neurons, such as serotonergic and GABAergic neurons, as well as proliferating neural progenitors positive for KI67, were also observed as minor populations (<ce:cross-ref refid="fig1" id="crosref0165">Figures 1</ce:cross-ref>Q and 1R). OCT4 was not detected by immunocytochemistry or flow cytometry in the differentiation culture even from the retroviral iPSCs (<ce:cross-ref refid="fig1" id="crosref0170">Figure 1</ce:cross-ref>O).</ce:para></ce:section><ce:section id="sec2.2" view="all"><ce:section-title id="sectitle0040">Expression of Major Histocompatibility Complex by Monkey iPSCs In Vitro</ce:section-title><ce:para id="p0045" view="all">Next, we investigated the expression of major histocompatibility complex class I (MHC-I) in iPSC-derived neural cells. Flow cytometry using antibodies against human leukocyte antigen (HLA)-A, HLA-B, and HLA-C revealed that mature neurons on days 35 and 71 expressed only a low level of MHC-I, and that the expression was enhanced in response to interferon gamma (IFN-Î³: 25 ng/ml for 48 hr; <ce:cross-ref refid="fig2" id="crosref0175">Figure 2</ce:cross-ref><ce:float-anchor refid="fig2"/>A). The expression level of the mRNAs was approximately 1:100 compared with peripheral blood cells in both fibroblast- and blood-cell-derived iPSCs, which was again increased by exposure to IFN-Î³ (<ce:cross-ref refid="fig2" id="crosref0180">Figure 2</ce:cross-ref>B). These results suggest that donor-derived neurons could express MHC-I when INF-Î³ was secreted by the host brain under inflammatory conditions.</ce:para><ce:para id="p0050" view="all">To ensure that the MHC-Is of the host animal and donor cells were mismatched in the allotransplantation cases, we performed genotyping of the expressed <ce:italic>MHCs</ce:italic> from the monkeys, which were purpose-bred, second-generation (F2), captive-born animals. As shown in <ce:cross-ref refid="fig2" id="crosref0185">Figures 2</ce:cross-ref>C and 2E, and <ce:cross-ref refid="app2" id="crosref0190">Table S1</ce:cross-ref>, each monkey expressed different MHCs in terms of the A and B alleles. Based on these results, we chose the most mismatched combination for allotransplantation (<ce:cross-ref refid="fig2" id="crosref0195">Figures 2</ce:cross-ref>D and 2E).</ce:para></ce:section><ce:section id="sec2.3" view="all"><ce:section-title id="sectitle0045">Autografts Elicit Only a Minimal Immune Response in the Primate Brain</ce:section-title><ce:para id="p0055" view="all">We injected the iPSC-derived neural cells (day 28) into the original monkey as an autograft, and into the MHC-mismatched monkey as an allograft (<ce:cross-ref refid="fig2" id="crosref0200">Figure 2</ce:cross-ref>D). Each animal received six separate injections (â¼8.0 Ã 10<ce:sup loc="post">5</ce:sup> cells in a 4 Î¼l suspension per tract) in the left striatum, and was observed for 3.5-4 months without immunosuppression. In the brain, both brain-resident microglia and circulating immune cells work as key players in immunological responses. Once the microglia are activated, they develop antigen-presenting activity. PK11195 selectively binds to the translocator protein that is expressed on activated microglia (<ce:cross-refs refid="bib21 bib23" id="crosrefs0015">Shah et al., 1994; Vowinckel et al., 1997</ce:cross-refs>). Therefore, positron emission tomography (PET) studies with [<ce:sup loc="pre">11</ce:sup>C]PK11195 have been used to visualize brain inflammation in patients (<ce:cross-ref refid="bib5" id="crosref0205">Debruyne et al., 2003</ce:cross-ref>).</ce:para><ce:para id="p0060" view="all">In sequential PET studies, we observed increased uptake of [<ce:sup loc="pre">11</ce:sup>C]PK11195 in one allograft (animal No. 10) at 3 months (<ce:cross-ref refid="fig3" id="crosref0210">Figures 3</ce:cross-ref>A and 3B<ce:float-anchor refid="fig3"/>). We could not detect any apparent uptake in the other animals or at any other time points (<ce:cross-ref refid="app2" id="crosref0215">Figure S2</ce:cross-ref>). Intriguingly, the serum level of IFN-Î³ temporarily increased at 2 months after the transplant in three animals (<ce:cross-ref refid="fig3" id="crosref0220">Figure 3</ce:cross-ref>C). An immunofluorescence study conducted at 3.5-4 months showed that MHC-II<ce:sup loc="post">+</ce:sup> cells were more frequently found in allografts than in autografts, especially in the monkey with increased uptake of [<ce:sup loc="pre">11</ce:sup>C]PK11195 (<ce:cross-ref refid="fig3" id="crosref0225">Figure 3</ce:cross-ref>D, No. 10). The MHC-II staining never overlapped with that of GFP of the donor cells (<ce:cross-ref refid="fig3" id="crosref0230">Figure 3</ce:cross-ref>F), whereas it generally overlapped with that of IBA1 (<ce:cross-ref refid="fig3" id="crosref0235">Figure 3</ce:cross-ref>G), indicating that MHC-II was expressed by host-derived microglia. Consistently, the number and density of IBA1<ce:sup loc="post">+</ce:sup> cells were higher in allografts than in autografts (<ce:cross-ref refid="fig3" id="crosref0240">Figures 3</ce:cross-ref>E, 3H, and <ce:cross-ref refid="app2" id="crosref0245">S4</ce:cross-ref>C). An increase in the expression of MHC might trigger the recruitment of circulating immune cells, including T cells. An immunofluorescence study revealed that more CD45<ce:sup loc="post">+</ce:sup> cells (a marker for pan-leukocytes) accumulated in allografts compared with autografts (<ce:cross-ref refid="fig3" id="crosref0250">Figures 3</ce:cross-ref>I and 3J). Most of the CD45<ce:sup loc="post">+</ce:sup> cells were CD3<ce:sup loc="post">+</ce:sup> T cells, and 60% of them were CD8<ce:sup loc="post">+</ce:sup> killer T cells (<ce:cross-ref refid="fig3" id="crosref0255">Figures 3</ce:cross-ref>K and 3L). These findings suggest that an acquired immune response was elicited only in the allografts in the primate brain.</ce:para></ce:section><ce:section id="sec2.4" view="all"><ce:section-title id="sectitle0050">DA Neurons Survive in Both Types of Grafts, but a Higher Number Are Observed in Autografts</ce:section-title><ce:para id="p0065" view="all">In order to evaluate the survival of the grafted cells, we performed MRI scanning and a histological analysis at 3-4 months posttransplantation (<ce:cross-ref refid="fig4" id="crosref0260">Figure 4</ce:cross-ref><ce:float-anchor refid="fig4"/>). Hematoxylin and eosin (H&amp;E) staining and immunostaining for GFP of the brain slices demonstrated that the grafted cells survived in both auto- and allotransplantation without immunosuppression (<ce:cross-ref refid="fig4" id="crosref0265">Figures 4</ce:cross-ref>A-4F). Furthermore, there were no significant differences in volume between the auto- and allografts (<ce:cross-ref refid="fig4" id="crosref0270">Figure 4</ce:cross-ref>K). Immunostaining for tyrosine hydroxylase (TH), a marker for DA neurons, revealed that a large number of DA neurons (4,428 Â± 1,130 per tract, n = 22) survived in the autografts (<ce:cross-ref refid="fig4" id="crosref0275">Figures 4</ce:cross-ref>G, 4H, 4L, and 4M). The surviving DA neurons coexpressed the markers of a mesencephalic phenotype, such as FOXA2, NURR1, and the dopamine transporter (DAT) (<ce:cross-ref refid="fig4" id="crosref0280">Figures 4</ce:cross-ref>N-4P). Even in allografts without immunosuppression, the TH<ce:sup loc="post">+</ce:sup> neurons survived well (2,247 Â± 641 per tract, n = 22), but the number and density were lower than in autografts (<ce:cross-ref refid="fig4" id="crosref0285">Figures 4</ce:cross-ref>I, 4J, 4L, and 4M). We also found a small number of astrocytes (GFP<ce:sup loc="post">+</ce:sup>/GFAP<ce:sup loc="post">+</ce:sup>), as well as mature neurons (GFP<ce:sup loc="post">+</ce:sup>/NEUN<ce:sup loc="post">+</ce:sup>), in vivo (<ce:cross-ref refid="app2" id="crosref0290">Figure S4</ce:cross-ref>B).</ce:para></ce:section></ce:section><ce:section id="sec3" view="all"><ce:section-title id="sectitle0055">Discussion</ce:section-title><ce:para id="p0070" view="all">In this study, we induced DA neurons from monkey iPSCs by directed differentiation in vitro, and demonstrated that autologous transplantation of the iPSC-derived cells elicited only a minimal immune response in the nonhuman primate brain. Previous reports have suggested that either autologous grafts of iPSC-derived neural cells (<ce:cross-refs refid="bib8 bib14" id="crosrefs0020">Emborg et al., 2013; Maria et al., 2013</ce:cross-refs>) or allogeneic grafts of fetal ventral mesencephalic cells (<ce:cross-ref refid="bib20" id="crosref0295">Redmond et al., 2008</ce:cross-ref>) can survive in a primate brain without immunosuppression. None of these studies, however, directly compared the immunogenicity of autologous grafts with that of allogeneic ones. Our results clearly show differences in both immunogenicity and cell survival between these two types of grafts, and support the idea that immunosuppression is not necessary for autologous transplantation of iPSC-derived neural cells into the brain. The [<ce:sup loc="pre">11</ce:sup>C]PK11195 PET study was useful for real-time visualization of this phenomenon. Furthermore, this technique can also be applied to patients in the clinical setting, which would help to determine when and if immunosuppressive drugs can be withdrawn.</ce:para><ce:para id="p0075" view="all">Although we did not examine acute immune responses or inflammation within 48 hr, it is noteworthy that the responses were observed 2 or 3 months posttransplantation. In the case of iPSC-based transplantation, there are four possible mechanisms that can cause inflammatory and immune responses: (1) direct allorecognition of mismatched MHC or minor antigens of the donor cells, (2) indirect allorecognition through host-derived antigen-presenting cells, (3) expression of fetal antigens due to immature stem cells or remaining transgenes, and (4) mechanical damage rather than MHC mismatch. Because of the low expression level of MHC-I by the donor cells, direct allorecognition is unlikely to be the main cause. However, donor-cell-derived astrocytes (<ce:cross-ref refid="app2" id="crosref0300">Figure S4</ce:cross-ref>B), which can express both MHC-I and MHC-II to recruit T cells in response to IFN-Î³ (<ce:cross-refs refid="bib1 bib4" id="crosrefs0025">Akesson et al., 2009; Chastain et al., 2011</ce:cross-refs>), could be observed in the grafts. Furthermore, it takes a longer time for astrocytes to differentiate than neurons. Therefore, although there was no apparent expression of either MHC-I or MHC-II by the grafted GFP<ce:sup loc="post">+</ce:sup> cells, donor-derived astrocytes may have contributed to the direct reaction in the late stage. Considering the high expression level of MHC-II by host-derived microglia in the allografts (<ce:cross-ref refid="fig3" id="crosref0305">Figures 3</ce:cross-ref>D-3G), indirect allorecognition seems to have played a major role in the present study. This requires the internalization and processing of the alloantigens, which are then recognized in peptidic form bound to recipient MHC-II molecules, possibly accounting for the late onset of the immune response.</ce:para><ce:para id="p0080" view="all">Autografts derived from iPSCs generated by retroviral vectors resulted in the accumulation of larger numbers of IBA1<ce:sup loc="post">+</ce:sup> and CD45<ce:sup loc="post">+</ce:sup> cells compared with those generated using episomal vectors, probably due to the residual expression of the transgenes (<ce:cross-ref refid="app2" id="crosref0310">Figure S3</ce:cross-ref>). This indicates that residual transgenes can be immunogenic, and that it is therefore critical to use integration-free iPSCs. Mechanical damage caused by needle trauma can also activate host astrocytes and microglia to secrete proinflammatory cytokines, which recruit leukocytes. Consistently, we found IBA1<ce:sup loc="post">+</ce:sup> cells along the needle tract in the animals that received control injections (<ce:cross-ref refid="fig3" id="crosref0315">Figures 3</ce:cross-ref>E and <ce:cross-ref refid="app2" id="crosref0320">S4</ce:cross-ref>C), but this was limited to a small area and not likely to play a major role.</ce:para><ce:para id="p0085" view="all">Another important finding is that, in spite of the immune responses mounted by the host brain, a substantial number of TH<ce:sup loc="post">+</ce:sup> cells survived in the allografts. This is consistent with previous clinical reports of human fetal cell transplantation. Postmortem analyses of the patients revealed robust survival of DA neurons in spite of the fact that numerous immune cells were present around the graft (<ce:cross-ref refid="bib12" id="crosref0325">Kordower et al., 1997</ce:cross-ref>). In two double-blind clinical trials, immunosuppressive drugs were never used (<ce:cross-ref refid="bib9" id="crosref0330">Freed et al., 2001</ce:cross-ref>) or were withdrawn after 6 months (<ce:cross-ref refid="bib19" id="crosref0335">Olanow et al., 2003</ce:cross-ref>). In these cases, the cells from multiple fetuses were used without HLA matching, but more than 50,000 TH<ce:sup loc="post">+</ce:sup> cells had survived after several years. Our quantitative PCR (qPCR) study in vitro showed that the expression of MHC-I increased in response to IFN-Î³, but the expression level was still 1/10 that of untreated monkey peripheral blood cells (<ce:cross-ref refid="fig2" id="crosref0340">Figure 2</ce:cross-ref>B). The in vivo studies revealed that the serum level of IFN-Î³ increased at 2 months, and CD45<ce:sup loc="post">+</ce:sup> cells (including CD8<ce:sup loc="post">+</ce:sup> cells) accumulated in the allografts 3.5-4 months after the transplant. On the other hand, the levels of INF-Î³ in the cerebrospinal fluid (CSF) and the levels of tumor necrosis factor Î± (TNF-Î±) in both the serum and CSF were below the limit of detection by ELISA (data not shown). An immunofluorescence study did not reveal any apparent expression of MHC-I by the grafted cells (<ce:cross-ref refid="app2" id="crosref0345">Figure S4</ce:cross-ref>A). Therefore, it is possible that the immune response in the primate brain was not strong enough to reject all of the donor cells. These findings closely correlate with the results of previous murine experiments (<ce:cross-refs refid="bib11 bib22" id="crosrefs0030">Hudson et al., 1994; Shinoda et al., 1995</ce:cross-refs>). To apply our findings to a more clinically relevant setting, we investigated the expression of HLA-I during neural differentiation of human ESCs (hESCs) and iPSCs by qPCR (<ce:cross-ref refid="app2" id="crosref0350">Figure S4</ce:cross-ref>D). The expression level was 1/100 compared with that of human peripheral blood cells in both hESCs and iPSCs, and it was similarly elevated in response to IFN-Î³. It is difficult to precisely compare immunogenicity in monkeys with that in humans, but the low expression level of MHC-I by the donor cells may account for the mild rejection in both monkey and human neural transplantation.</ce:para><ce:para id="p0090" view="all">Our results indicate that autologous transplantation is beneficial in terms of the immune response and cell survival. However, this strategy is associated with higher costs and labor. An alternative method is allogeneic transplantation using HLA-matched iPSC stocks (<ce:cross-refs refid="bib17 bib16 bib6" id="crosrefs0035">Okita et al., 2011; Nakatsuji et al., 2008; Deleidi et al., 2011</ce:cross-refs>). Therefore, as a next step, it is critical to determine whether autografts have advantages over HLA-matched allografts and HLA-mismatched allografts with immunosuppression. To answer this question, it will be necessary to establish iPSCs from MHC-homozygous monkeys and transplant the iPSC-derived cells into monkeys with the identical MHC haplotype. The precise influence of HLA mismatch therefore needs to be explored in such future studies.</ce:para></ce:section><ce:section id="sec4" role="materials-methods" view="all"><ce:section-title id="sectitle0060">Experimental Procedures</ce:section-title><ce:section id="sec4.1" view="all"><ce:section-title id="sectitle0065">Nonhuman Primates</ce:section-title><ce:para id="p0095" view="all">Eight purpose-bred male cynomolgus monkeys (<ce:italic>Macaca fascicularis</ce:italic>) were used for iPSC generation and transplantation. The animal experiments were performed in accordance with the Guidelines for Animal Experiments of Kyoto University, the Institutional Animal Care and Use Committee of Kobe Institute in RIKEN, and the Guide for the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources (Washington, DC, USA). See also <ce:cross-ref refid="app2" id="crosref0355">Supplemental Experimental Procedures</ce:cross-ref>.</ce:para></ce:section><ce:section id="sec4.2" view="all"><ce:section-title id="sectitle0070">Generation and Neural Differentiation of iPSCs</ce:section-title><ce:para id="p0100" view="all">Fibroblasts from the oral mucosa were transfected retrovirally with five transgenes (<ce:italic>OCT3/4</ce:italic>, <ce:italic>SOX2</ce:italic>, <ce:italic>KLF4</ce:italic>, <ce:italic>L-MYC</ce:italic>, and <ce:italic>LIN28</ce:italic>) (<ce:cross-ref refid="bib17" id="crosref0360">Okita et al., 2011</ce:cross-ref>). PBMCs were transfected with a combination of plasmid vectors (<ce:italic>OCT3/4</ce:italic>, <ce:italic>SOX2</ce:italic>, <ce:italic>KLF4</ce:italic>, <ce:italic>L-MYC</ce:italic>, <ce:italic>LIN28</ce:italic>, shRNA for TP53, and <ce:italic>EBNA1</ce:italic>) as described previously (<ce:cross-ref refid="bib18" id="crosref0365">Okita et al., 2013</ce:cross-ref>). The primate iPSCs were maintained on mouse embryonic fibroblast feeders treated with mitomycin-C (Sigma-Aldrich). They were differentiated into DA neurons through the SFEBq method (<ce:cross-ref refid="bib7" id="crosref0370">Eiraku et al., 2008</ce:cross-ref>) with dual SMAD inhibitors (<ce:cross-refs refid="bib3 bib15" id="crosrefs0040">Chambers et al., 2012; Morizane et al., 2011</ce:cross-refs>; <ce:cross-ref refid="fig1" id="crosref0375">Figure 1</ce:cross-ref>N). The cells were transplanted on day 28 of differentiation. For in vitro analysis, the cells were dissociated with Accumax (Innovative Cell Technologies) on day 28 and cultured on eight-well glass chamber slides coated with poly-l-ornithine and laminin for an additional 11 days (for a total of 39 days).</ce:para></ce:section><ce:section id="sec4.3" view="all"><ce:section-title id="sectitle0075">Genotyping of MHC</ce:section-title><ce:para id="p0105" view="all"><ce:italic>MHC</ce:italic> genotypes were assigned by comparing the sequences with known <ce:italic>MHC</ce:italic> allele sequences released from the Immuno Polymorphism Database (<ce:inter-ref xlink:href="http://www.ebi.ac.uk/ipd/index.html" id="intref0010" xlink:type="simple">http://www.ebi.ac.uk/ipd/index.html</ce:inter-ref>). See also <ce:cross-ref refid="app2" id="crosref0380">Supplemental Experimental Procedures</ce:cross-ref>.</ce:para></ce:section><ce:section id="sec4.4" view="all"><ce:section-title id="sectitle0080">Immunostaining and Histological Analyses</ce:section-title><ce:para id="p0110" view="all">For in vivo studies, the fixed frozen brains were sliced at 40 Î¼m thickness and immunologically stained via the free-floating method. The primary antibodies used are listed in <ce:cross-ref refid="app2" id="crosref0385">Table S3</ce:cross-ref>. See also <ce:cross-ref refid="app2" id="crosref0390">Supplemental Experimental Procedures</ce:cross-ref>.</ce:para></ce:section><ce:section id="sec4.5" view="all"><ce:section-title id="sectitle0085">MRI and PET Studies</ce:section-title><ce:para id="p0115" view="all">PET scans with [<ce:sup loc="pre">11</ce:sup>C]PK11195 were performed with the use of an animal PET scanner (microPET Focus220; Siemens Medical Solutions) to identify the activation of microglia. High-resolution T1-weighted and T2-weighted images were obtained using a 3T MRI scanner (MAGNETOM Verio; Siemens AG) to identify the injection site of grafts in the postero-dorsal striatum and to evaluate graft survival. See also <ce:cross-ref refid="app2" id="crosref0395">Supplemental Experimental Procedures</ce:cross-ref>.</ce:para></ce:section><ce:section id="sec4.6" view="all"><ce:section-title id="sectitle0090">Transplantation</ce:section-title><ce:para id="p0120" view="all">Floating aggregates (day 28) were harvested and dissociated into small clumps of 20-30 cells with Accumax. The cells were suspended in the last culture medium (<ce:cross-ref refid="fig1" id="crosref0400">Figure 1</ce:cross-ref>N), which was neurobasal medium with B27 with added ascorbic acid, dibutyryl-cAMP, glial-cell-line-derived neurotrophic factor, and brain-derived neurotrophic factor. We also added a ROCK inhibitor, Y27632, to increase the survival of the donor cells. The suspension was prepared at a concentration of 2 Ã 10<ce:sup loc="post">5</ce:sup> cells/Î¼l, and 4 Î¼l of the suspension was injected through a 22-gauge needle with a Hamilton syringe. We made six (two coronal Ã three sagittal) tracts of injection in one side of the putamen. In total, 4.8 Ã 10<ce:sup loc="post">6</ce:sup> cells per animal (8.0 Ã 10<ce:sup loc="post">5</ce:sup> cells/tract Ã 6 tracts) were injected into one side of the putamen according to the coordinate decided by the MRI image of each monkey. The same volume of the culture medium was injected to the contralateral side as control. No immunosuppressant was used. Under deep anesthesia, the animals were sacrificed and perfused transcardially with 4% paraformaldehyde after 3.5-4 months of observation.</ce:para></ce:section><ce:section id="sec4.7" view="all"><ce:section-title id="sectitle0095">Statistics</ce:section-title><ce:para id="p0125" view="all">The data were expressed as the mean Â± SD or mean Â± SEM, and differences were tested by commercially available software Prism 6 (GraphPad). With regard to the histological data for the auto- and allo-tracts, after confirming normal distribution, we proceeded to perform statistical analyses with ratio paired t tests. Some tracts were omitted from the assessment because of technical problems; p values &lt; 0.05 were considered to be significant.</ce:para></ce:section></ce:section></ce:sections><ce:acknowledgment id="ack0010" view="all"><ce:section-title id="sectitle0100">Acknowledgments</ce:section-title><ce:para id="p0130" view="all">We thank Ms. E. Yamasaki and Mr. K. Kubota for their technical assistance, Drs. K. Tanaka and T. Sato for the genetic analyses, Dr. Y. Yamada for his valuable advice on the histological studies, Dr. Y. Ono for providing antibodies, and Dr. H. Kawamoto for his critical advice on the manuscript. This study was supported by grants from the Highway Project for Realization of Regenerative Medicine (Ministry of Education, Culture, Sports, Science and Technology), the Funding Program for World-Leading Innovative R&amp;D on Science and Technology (FIRST Program, Japan Society for the Promotion of Science), and the Shimizu Foundation for Immunology and Neuroscience Grant for 2012.</ce:para></ce:acknowledgment><ce:appendices view="all"><ce:section id="app1" view="compact-standard"><ce:section-title id="sectitle0105">Supplemental Information</ce:section-title><ce:para id="p0135" view="all">Supplemental Information includes Supplemental Experimental Procedures, four figures, and three tables and can be found with this article online at <ce:inter-ref xlink:href="doi:10.1016/j.stemcr.2013.08.007" id="intref0015" xlink:type="simple">http://dx.doi.org/10.1016/j.stemcr.2013.08.007</ce:inter-ref>.</ce:para></ce:section><ce:section id="app2" view="extended"><ce:section-title id="sectitle0110">Supplemental Information</ce:section-title><ce:para id="p0140" view="all"><ce:display><ce:e-component id="mmc1"><ce:label>Document S1. Supplemental Experimental Procedures and Figures S1-S4 and Tables S1-S3</ce:label><ce:link locator="mmc1"/></ce:e-component></ce:display></ce:para></ce:section></ce:appendices></body><tail view="all"><ce:bibliography id="cebib0010" view="all"><ce:section-title id="sectitle0115">References</ce:section-title><ce:bibliography-sec id="cebibsec0010" view="all"><ce:bib-reference id="bib1"><ce:label>Akesson et al., 2009</ce:label><sb:reference id="sref1"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Akesson</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Wolmer-Solberg</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Cederarv</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Falci</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Odeberg</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Human neural stem cells and astrocytes, but not neurons, suppress an allogeneic lymphocyte response</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stem Cell Res. (Amst.)</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>56</sb:first-page><sb:last-page>67</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>Araki et al., 2013</ce:label><sb:reference id="sref2"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Araki</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Uda</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Hoki</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Sunayama</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Nakamura</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Ando</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Sugiura</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Ideno</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Shimada</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Nifuji</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Abe</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>494</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>100</sb:first-page><sb:last-page>104</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>Chambers et al., 2012</ce:label><sb:reference id="sref3"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.M.</ce:given-name><ce:surname>Chambers</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Qi</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Mica</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:author><ce:given-name>X.J.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Niu</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Bilsland</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Cao</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Stevens</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Whiting</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>30</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>715</sb:first-page><sb:last-page>720</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>Chastain et al., 2011</ce:label><sb:reference id="sref4"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Chastain</ce:surname></sb:author><sb:author><ce:given-name>D.S.</ce:given-name><ce:surname>Duncan</ce:surname></sb:author><sb:author><ce:given-name>J.M.</ce:given-name><ce:surname>Rodgers</ce:surname></sb:author><sb:author><ce:given-name>S.D.</ce:given-name><ce:surname>Miller</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The role of antigen presenting cells in multiple sclerosis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Biochim. Biophys. Acta</sb:maintitle></sb:title><sb:volume-nr>1812</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>265</sb:first-page><sb:last-page>274</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>Debruyne et al., 2003</ce:label><sb:reference id="sref5"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Debruyne</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Versijpt</ce:surname></sb:author><sb:author><ce:given-name>K.J.</ce:given-name><ce:surname>Van Laere</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>De Vos</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Keppens</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Strijckmans</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Achten</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Slegers</ce:surname></sb:author><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Dierckx</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Korf</ce:surname></sb:author><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>De Reuck</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>PET visualization of microglia in multiple sclerosis patients using [11C]PK11195</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur. J. Neurol.</sb:maintitle></sb:title><sb:volume-nr>10</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>257</sb:first-page><sb:last-page>264</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>Deleidi et al., 2011</ce:label><sb:reference id="sref6"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Deleidi</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Hargus</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Hallett</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Osborn</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Isacson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Development of histocompatible primate-induced pluripotent stem cells for neural transplantation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stem Cells</sb:maintitle></sb:title><sb:volume-nr>29</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>1052</sb:first-page><sb:last-page>1063</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>Eiraku et al., 2008</ce:label><sb:reference id="sref7"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Eiraku</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Watanabe</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Matsuo-Takasaki</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Kawada</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yonemura</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Matsumura</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Wataya</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Nishiyama</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Muguruma</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Sasai</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>519</sb:first-page><sb:last-page>532</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>Emborg et al., 2013</ce:label><sb:reference id="sref8"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.E.</ce:given-name><ce:surname>Emborg</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Liu</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Xi</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Yin</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Lu</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Joers</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Swanson</ce:surname></sb:author><sb:author><ce:given-name>J.E.</ce:given-name><ce:surname>Holden</ce:surname></sb:author><sb:author><ce:given-name>S.C.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Induced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brain</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Rep.</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>646</sb:first-page><sb:last-page>650</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>Freed et al., 2001</ce:label><sb:reference id="sref9"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.R.</ce:given-name><ce:surname>Freed</ce:surname></sb:author><sb:author><ce:given-name>P.E.</ce:given-name><ce:surname>Greene</ce:surname></sb:author><sb:author><ce:given-name>R.E.</ce:given-name><ce:surname>Breeze</ce:surname></sb:author><sb:author><ce:given-name>W.Y.</ce:given-name><ce:surname>Tsai</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>DuMouchel</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Kao</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Dillon</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Winfield</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Culver</ce:surname></sb:author><sb:author><ce:given-name>J.Q.</ce:given-name><ce:surname>Trojanowski</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Transplantation of embryonic dopamine neurons for severe Parkinson's disease</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>N. Engl. J. Med.</sb:maintitle></sb:title><sb:volume-nr>344</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>710</sb:first-page><sb:last-page>719</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>Guha et al., 2013</ce:label><sb:reference id="sref10"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Guha</ce:surname></sb:author><sb:author><ce:given-name>J.W.</ce:given-name><ce:surname>Morgan</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Mostoslavsky</ce:surname></sb:author><sb:author><ce:given-name>N.P.</ce:given-name><ce:surname>Rodrigues</ce:surname></sb:author><sb:author><ce:given-name>A.S.</ce:given-name><ce:surname>Boyd</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>407</sb:first-page><sb:last-page>412</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>Hudson et al., 1994</ce:label><sb:reference id="sref11"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Hudson</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Hoffman</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>StrÃ¶mberg</ce:surname></sb:author><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Hoffer</ce:surname></sb:author><sb:author><ce:given-name>J.W.</ce:given-name><ce:surname>Moorhead</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Allogeneic grafts of fetal dopamine neurons: behavioral indices of immunological interactions</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neurosci. Lett.</sb:maintitle></sb:title><sb:volume-nr>171</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>32</sb:first-page><sb:last-page>36</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>Kordower et al., 1997</ce:label><sb:reference id="sref12"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.H.</ce:given-name><ce:surname>Kordower</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Styren</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Clarke</ce:surname></sb:author><sb:author><ce:given-name>S.T.</ce:given-name><ce:surname>DeKosky</ce:surname></sb:author><sb:author><ce:given-name>C.W.</ce:given-name><ce:surname>Olanow</ce:surname></sb:author><sb:author><ce:given-name>T.B.</ce:given-name><ce:surname>Freeman</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Fetal grafting for Parkinson's disease: expression of immune markers in two patients with functional fetal nigral implants</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Transplant.</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>213</sb:first-page><sb:last-page>219</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>Lindvall and BjÃ¶rklund, 2011</ce:label><sb:reference id="sref13"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Lindvall</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>BjÃ¶rklund</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Cell therapeutics in Parkinson's disease</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neurotherapeutics</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>539</sb:first-page><sb:last-page>548</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>Maria et al., 2013</ce:label><sb:reference id="sref14"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Maria</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Helle</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Tristan</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Gaynor</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Arnar</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Michele</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Teresia</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Oliver</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Roger</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stem Cells</sb:maintitle></sb:title><sb:volume-nr>31</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>1548</sb:first-page><sb:last-page>1562</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>Morizane et al., 2011</ce:label><sb:reference id="sref15"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Morizane</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Doi</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Kikuchi</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Nishimura</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Takahashi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci. Res.</sb:maintitle></sb:title><sb:volume-nr>89</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>117</sb:first-page><sb:last-page>126</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>Nakatsuji et al., 2008</ce:label><sb:reference id="sref16"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Nakatsuji</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Nakajima</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Tokunaga</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>HLA-haplotype banking and iPS cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>739</sb:first-page><sb:last-page>740</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>Okita et al., 2011</ce:label><sb:reference id="sref17"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Okita</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Matsumura</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Sato</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Okada</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Morizane</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Okamoto</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Hong</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Nakagawa</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Tanabe</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Tezuka</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A more efficient method to generate integration-free human iPS cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Methods</sb:maintitle></sb:title><sb:volume-nr>8</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>409</sb:first-page><sb:last-page>412</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>Okita et al., 2013</ce:label><sb:reference id="sref18"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Okita</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Yamakawa</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Matsumura</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Sato</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Amano</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Watanabe</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Goshima</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Yamanaka</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>An efficient nonviral method to generate integration-free human human-induced pluripotent cells from cord blood and peripheral blood cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stem Cells</sb:maintitle></sb:title><sb:volume-nr>31</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>458</sb:first-page><sb:last-page>466</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>Olanow et al., 2003</ce:label><sb:reference id="sref19"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.W.</ce:given-name><ce:surname>Olanow</ce:surname></sb:author><sb:author><ce:given-name>C.G.</ce:given-name><ce:surname>Goetz</ce:surname></sb:author><sb:author><ce:given-name>J.H.</ce:given-name><ce:surname>Kordower</ce:surname></sb:author><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Stoessl</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Sossi</ce:surname></sb:author><sb:author><ce:given-name>M.F.</ce:given-name><ce:surname>Brin</ce:surname></sb:author><sb:author><ce:given-name>K.M.</ce:given-name><ce:surname>Shannon</ce:surname></sb:author><sb:author><ce:given-name>G.M.</ce:given-name><ce:surname>Nauert</ce:surname></sb:author><sb:author><ce:given-name>D.P.</ce:given-name><ce:surname>Perl</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Godbold</ce:surname></sb:author><sb:author><ce:given-name>T.B.</ce:given-name><ce:surname>Freeman</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ann. Neurol.</sb:maintitle></sb:title><sb:volume-nr>54</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>403</sb:first-page><sb:last-page>414</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>Redmond et al., 2008</ce:label><sb:reference id="sref20"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.E.</ce:given-name><ce:surname>Redmond</ce:surname><ce:suffix>Jr.</ce:suffix></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Vinuela</ce:surname></sb:author><sb:author><ce:given-name>J.H.</ce:given-name><ce:surname>Kordower</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>Isacson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Neurobiol. Dis.</sb:maintitle></sb:title><sb:volume-nr>29</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>103</sb:first-page><sb:last-page>116</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>Shah et al., 1994</ce:label><sb:reference id="sref21"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Shah</ce:surname></sb:author><sb:author><ce:given-name>S.P.</ce:given-name><ce:surname>Hume</ce:surname></sb:author><sb:author><ce:given-name>V.W.</ce:given-name><ce:surname>Pike</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Ashworth</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>McDermott</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nucl. Med. Biol.</sb:maintitle></sb:title><sb:volume-nr>21</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>573</sb:first-page><sb:last-page>581</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>Shinoda et al., 1995</ce:label><sb:reference id="sref22"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Shinoda</ce:surname></sb:author><sb:author><ce:given-name>J.L.</ce:given-name><ce:surname>Hudson</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>StrÃ¶mberg</ce:surname></sb:author><sb:author><ce:given-name>B.J.</ce:given-name><ce:surname>Hoffer</ce:surname></sb:author><sb:author><ce:given-name>J.W.</ce:given-name><ce:surname>Moorhead</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Olson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Allogeneic grafts of fetal dopamine neurons: immunological reactions following active and adoptive immunizations</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Brain Res.</sb:maintitle></sb:title><sb:volume-nr>680</sb:volume-nr></sb:series><sb:date>1995</sb:date></sb:issue><sb:pages><sb:first-page>180</sb:first-page><sb:last-page>195</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib23"><ce:label>Vowinckel et al., 1997</ce:label><sb:reference id="sref23"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Vowinckel</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Reutens</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Becher</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Verge</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Evans</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Owens</ce:surname></sb:author><sb:author><ce:given-name>J.P.</ce:given-name><ce:surname>Antel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurosci. Res.</sb:maintitle></sb:title><sb:volume-nr>50</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>345</sb:first-page><sb:last-page>353</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib24"><ce:label>Zhao et al., 2011</ce:label><sb:reference id="sref24"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Zhao</ce:surname></sb:author><sb:author><ce:given-name>Z.N.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>Z.</ce:given-name><ce:surname>Rong</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Xu</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Immunogenicity of induced pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>474</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>212</sb:first-page><sb:last-page>215</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></xocs:serial-item></xocs:doc>
